By Rebecca Victoria Olmos | TheCannifornian.com Correspondent

What are topicals?

Cannabis is beneficial for our bodies through traditional ingestion methods like smoking or eating and when applied to the body externally through topicals. Topicals are cannabis-infused lotions, creams, oils, or balms that are applied directly to the skin. Since they do not cause any psychoactive effects, they are mainly used in an attempt to help with localized pain, inflammation, and some skin conditions.

How do they work?

Cannabis topicals come in various ratios of cannabinoids like THC and CBD. When applied to the skin, these cannabinoids bind to the cannabinoid receptors in the skin, nerves, and muscles. These receptors are part of an extensive endocannabinoid system that helps to regulate various biological functions throughout the body, like sleep, appetite, pain, and inflammation.

Topicals do not penetrate through the skin to enter the bloodstream, so they do not cause the user any psychoactive effects. It’s important to note because topicals can be confused with transdermals which may cause psychoactive effects. Transdermals contain skin penetrating enhancers that help push the cannabinoids past the epidermis or first layer of skin into the bloodstream.

What might they help?

People have used cannabis-infused topicals for things like arthritis relief, muscle soreness, tension, cramps, psoriasis, eczema, and even headaches. Since cannabis receptors are all over your body, you can even use cannabis topicals for sexual enhancement through infused lubricants.

THC or CBD?

You can be purchase topicals in hemp varieties at health stores or cannabis-derived ones at your nearest dispensary. They will all have different dosages of THC or CBD. Remember that everyone is different and what works for one might not work for you. A good rule of thumb is that if you’re looking for relief from muscle-related issues, steer towards THC-rich products. For joint pain or inflammation, try CBD-rich.

Don’t get discouraged if one product doesn’t work for you. Be open, and experiment with different brands, cannabinoid ratios, and ingredients. And if all else fails, you can always try and make your own infused topical!

From life-threatening viruses to raging wildfires to skyrocketing unemployment, 2020 is testing the human spirit in unimaginable ways. One such symptom of this year’s chaos is maintaining proper mental health as bad news continually wafts through televisions sets like a skunk’s scent from a bedroom window.

Anxiety and depression are running amok. Some studies discovered that “In mid-July, 53% of adults in the United States reported that their mental health has been negatively impacted due to worry and stress over the coronavirus. This is significantly higher than the 32% reported in March.”

With so much uncertainly swirling about, how are CBD, anxiety and depression intertwined, and how can cannabidiol products help during such trying times?

CBD and Anxiety

In 2011, a study reported that CBD possessed the power to reduced anxiety during public speaking for those anxious in social situations. How was that possible?

CBD aids the neurotransmitters already bouncing around your brain by promoting the release of serotonin. It’s a potential alternative to sketchy “happy pills” like Prozac, and you can purchase it at outlets as popular as Whole Foods.

No grocery stores in your area with CBD items? No worries. Products are legal to ship to your doorstep in the United States.

CBD and Depression

CBD can help with depression, similar to relieving anxiety issues. Early studies on canines and CBD showed great promise in raising low serotonin levels.

Science has only progressed in purporting that CBD has incredible antidepressant effects, but it’s always smart to speak with your doctor about your unique situation, including how many milligrams to begin with and any potential side effects.

Say Goodbye to Insomnia

Pandemic or not, you know full well how difficult everyday tasks are following a night of fitful sleep, and a lack of solid slumber can exasperate anxiety and depression.

To maximize your chances of saying goodnight to insomnia, check out products consisting of tinctures easily added to evening teas, soothing bath salts, yummy edibles (don’t worry, no THC here) and more.

In Sickness and in Health

Whether you’re battling a life-threatening disease, anxiety and depression or simply looking to feel your best, CBD helps in additional ways:

• Reduces pain and inflammation
• Can help increase the lack of appetite often arising from anxiety or depression
• Exercise is closely linked to alleviating anxiety and depression. CBD can provide muscle recovery afterward
• Offers a viable alternative to traditional drugstore items unhelpful in providing relief
• Confidence in knowing products are legal and regulated
• Depending on where you live, home delivery is possible

These are challenging times, to say the least, and we aren’t clear of the forest yet, but with an assist from over-the-counter CBD items, you can increase your odds of keeping anxiety and depression at bay.

The negative stigmas attached to cannabis continue to fade away like a puff of smoke in the wind. Most people are now well aware of the therapeutic benefits of the cannabis plant and its cousin hemp. Investors are certainly aware of the massive industry unfolding.

Against this backdrop, cannabis operations have moved from the back alley to the boardroom and innovation is thriving. The perfect storm of booming demand for product and operational efficiency has led to a proliferation of automated technology throughout the supply chain.

For JackSam Corp. (OTCQB: JKSM), which does business under the moniker Convectium, this is the perfect environment to continue roll-out of its disruptive automated solution suite that fills, caps and packages THC and CBD concentrates 60-times faster than antiquated manual methods that still dominate the market.

Click here to see the company investor presentation

For SinglePoint, Inc. (OTCQB: SING), a diversified holding firm with portfolio companies in cannabis, hemp, digital payments and solar, taking a piece of Convectium in 2017 was an investment that keeps on giving.  In March 2017, SinglePoint made an $800,000 cash-and-stock investment for 10% of then-privately held Convectium.

Click here to see the company corporate presentation

SinglePoint still holds 6.0% of JKSM outstanding stock.

The Biggest Thing Since the Dotcom Boom

Vilified for decades, cannabis is now being trumpeted as a serious medical breakthrough.

Cannabis cannabinoids can be found in more than 1,000 products, ranging from edibles to beverages to pet products to skin creams. These cannabinoids generally consist of CBD (cannabidiol), a non-intoxicating component of cannabis and hemp, and THC (tetrahydrocannabinol), the part of cannabis responsible for the psychoactive “high” often associated with marijuana.

The world is recognizing the medical benefits (and lack of side effects) of CBD. Hemp, which became legal across the U.S. at the start of 2019 through the passage of the Farm Bill, is defined as cannabis sativa containing less than 0.3% THC. In January 2018, the World Doping Agency removed CBD from its banned substance list, further validating its efficacy and safety.

33 U.S. states have legalized cannabis for medical uses, while 10 states and Washington, D.C. allow recreational uses. Last October, Canada legalized marijuana for all adults but products have been limited. Modified legislation will open the Canadian markets to a variety of new cannabis products, including extracts. That means that about 260 million people in North America has access to cannabis in one form or another.

To that end, it’s no surprise that the industry experts at Arcview Market Research and BDS Analytics are calling for the legal cannabis market in the U.S. alone to reach $22.2 billion in 2022.

Leading the growth is concentrates, which, according to the BDS’s GreenEdge have experienced 22.1% compound annual growth across 2014-2018 to now make up one-third of the total cannabis market. A deeper dive shows the cannabis oil market segment is surging, forecast to grow at a stunning 46.9% CAGR from 2019-2025 to reach $2.16 billion.

Running Circles Around Competition

Convectium is the inventor of the world’s first cannabis oil filling system and proprietary packaging systems. This is a major advancement at a time when about 80% of all concentrate products (vapes and pods) are filled manually.  By hand, oil cartridge fills are completed at a paltry 75 per hour.  Convectium’s 710 Shark system can exceed that in less than a minute on its way to produce between 6,000-12,000 in an hour.

As the image shows, none of the limited amount of competition even comes close to the speed or diversity of the 710 Shark.  When the 710 Captain and 710 Seal are added to the assembly line, the processes of “rack, fill, cap and pack” that all concentrates go through are completed by Convectium products with dramatically improve speed, while reducing waste by as much as 42%.

“Where else can one person do 6,000 cartridges, including filling and putting into blister packs, in one hour?  The answer is ‘nowhere’,” commented SinglePoint CEO Greg Lambrecht in a phone conversation with CFN Media.  “We were confident in the investment in Convectium 2-1/2 years ago and are greatly looking forward to the coming years under their new business model,” he added.

Lambrecht was referring to Convectium recently switching from a “closed system” to an “open source” business model. This is a savvy move by Convectium to make its vape, pod and cartridge trays and equipment compatible with components produced by the majority of leading global manufacturers. For the first time, cannabis brands and co-packers can add the 710 line to existing filling operations, greatly improving efficiency and the bottom line.

Built in the U.S.A. with UL certification, Convectium is prepping for extracts becoming legal in Canada early in 2020 by making the machines CUL certified as well.

Charged with spearheading a sales push under the new strategy, cannabis industry veteran David Hall was brought on as Executive VP of Sales at Convectium.

Strength in Numbers

With over 100 customers using Convectium products, the brand has built a market presence.  As the industry gets ready to experience exponential growth, Convectium leadership is taking a more aggressive approach at an opportune time. Late in July, the company penned a distribution agreement with MainStem, a leading marketplace for ancillary cannabis products and centralized purchasing. Mainstem’s online platform offers over 10,000 products and cutting-edge e-procurement functionality as it re-shapes the industry standard for how business-to-business purchasing is done in the cannabis industry.

Click here to see the company investor presentation

Further, SinglePoint is much more than just a leading shareholder in Convectium.  SinglePoint’s family of companies all have synergies with each other. To that end, SinglePoint is building its own footprint in the private label market and will use Convectium products for its clients, as well as making referrals to drive more business to Convectium. It also owns SingleSeed, an e-commerce portal selling hemp-derived CBD products.

Click here to see the company corporate presentation

“[We] recently received sample vape pens from the company and have already received lots of interest, and an order” commented SinglePoint President Wil Ralston, succinctly adding, “The cutting-edge technology allows us to provide superior products to clients.”

A Prescient Decision

A couple years ago, Wall Street was bearish on legal cannabis, shaken by uncertainty about where the market was heading against the backdrop of prohibition at the federal level. SinglePoint got ahead of the curve, seeing Convectium’s vision for automation as the future of industry. Turns out they were both right, seizing the opportunity as technology now has spread throughout the entire cannabis value chain from growing to distribution. Still, no one does it as fast or as efficiently as Convectium.

Click Here to Receive CFN Media’s Newsletter Every Week in Your Inbox

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://www.cannabisfn.com(the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.

About Ash Stringer

The legalization of cannabis in Canada on October 17, 2018 was seen as a progressive and forward-thinking development.It put Canada at the forefront of this exciting new industry, as the only country other than Uruguay to legalize cannabis on a federal level. However as dynamic as this legislation was, it was limited in terms of what was initially included. Although flower was covered under these new laws, they excluded a huge part of the industry; edibles and concentrates.

A report by Arcview Market Research estimated that cannabis-based food and drink reached an estimated $1 billion in 2017 in North America. The same report estimates the edibles market could reach an astounding $4.1 billion in the US and Canada by 2022.

Canadian Edibles Market

The Canadian market is preparing to capitalize on this trend. In late December, Health Canada released draft regulations, which dictate that edible cannabis products should be fully legalized by October 17 of this year. A recent report from Deloitte entitled ‘Nurturing new growth: Canada gets ready for Cannabis 2.0’ estimates the annual market for alternative cannabis products to be $2.7 billion, with edibles contributing to over half of that.

Click here to see the company’s investor presentation

With this incredible business opportunity, producers and distributors are looking at ways to capitalize on this vast new sector of the market. One company which looks to be well-positioned in this category is Indiva Limited(TSXV:NDVA) (US:NDVAF).

As a Licensed Producer of medical grade cannabis, Indiva is perfectly positioned for Cannabis 2.0. It has a growing roster of brands which already produce and distribute a wide variety of cannabis products to users across Canada. As an established company, Indiva plans to use its Canadian operations as a platform to launch into the edibles market, once the surrounding legislation is finalized.

Facilities and Distribution

Indiva has a 100%-owned, 40,000 square foot indoor production facility in London, Ontario. Its facility is world class, with quality assurance and control. A clean product is ensured by its climate controlled system, as well as pest and pathogen control. Its GMP-compliant, aeroponic grow systems are environmentally friendly and highly advanced. Already producing medical grade THC, CBD and hybrid strains, Indiva is positioned to use this facility to produce equally high-grade edible cannabis products.

In early June Indiva received an amended license from Health Canada for three additional grow rooms and three additional processing rooms, bringing the company’s annual cultivation capacity to approximately 1,000kg. The increased flower capacity will serve as raw material for Indiva’s 70 tonne extraction facility which is scheduled for completion in Q3 of 2019. Indiva’s extraction system will produce some 4 million grams of distillate annually at full capacity with the potential to be more profitable than flower at current market conditions. The three newly licensed rooms will be immediately populated with plants, using advanced aeroponic grow technology, with the first harvest expected in less than 10 weeks.

Click here to see the company’s investor presentation

Indiva has a supply agreement in place with the Ontario Cannabis Store (OCS) and has been delivering on the order since February and is preparing to deliver gel capsules.The agreement with the OCS has resulted in Q1 net revenue gains for Indiva. The company is executing on plans to grow its facilities and product offerings and awaits approval and licensing from Health Canada. Going forward, the company aims to add further distribution agreements with retailers in other provinces in 2019, using its active sales team already located across the country.

In the longer-term, Indiva plans to use its Canadian operations as a blueprint to launch globally into new markets, as cannabis laws around the world continue to come into play.

Indiva already has agreements with US based companies to distribute internationally, and it has issued a Letter of Intent to acquire a cultivation license in Denmark, where a four year pilot program which began in January 2018 allows the sale of medical cannabis. This would give Indiva an early advantage in the European market, which should become particularly lucrative as laws liberalize across the continent.

Impressive Product Line

Among its brands, Indiva has aligned itself with high-quality and experienced edible companies, namely Ruby and Bhang. Both companies are powered by Indiva, and will use the company’s cannabis oil extractions as the basis for edible products.

Ruby is the world’s first edible brand made with organic and all-natural ingredients. The product line will consist of infused sugar and salt crystals, which allows users to easily incorporate them into food and drink for the ultimate in personalized edible cannabis consumption. The line also offers fruit-based chews, pancake and drink mixes, candies and prebiotic supplements. The line will be infused with Indiva’s THC, CBD or a hybrid combination of both, offering a wide selection for those who wish to ingest cannabis, not inhale it.

Bhang Chocolate is one of the most recognised cannabis brand houses on the planet. Drawing from its diverse team, Bhang brings together over a decade of experience in the cannabis industry to create its award-winning product line. With reliable dosing and a cannabis-free taste, Bhang’s products are the ultimate in premium edibles. In addition to its range of cannabis-infused chocolates, Bhang also offers vapes, gums and mouth sprays.

Experienced Leadership

Indiva is led by CEO, Director and Co-Founder Niel Marotta. Niel managed a portfolio of over $1 billion as a fund manager at a notable US firm. He was also Vice President of a TSX listed natural resource focused company, and subsequently worked as an investment banker. As a graduate of McGill University’s commerce programme, Niel is the perfect leader to guide Indiva into this exciting new branch of the cannabis industry.

Click here to see the company’s investor presentation

Between its state of the art facility, calculated distribution network and expanding product offering, Indiva has set its sights high as Canada’s legal market enters the next phase of its development, the cannabis 2.0 revolution. With analysts predicting this to be a multi-billion dollar segment of the marijuana industry, Indiva has taken intelligent and bold steps to lay the groundwork for its success as edibles are legalized in Canada.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

About Joy Crosby

Nowadays Cannabis business is increasing day by day. This is mainly due to providing licenses to many of the Cannabis companies who provide Cannabis only for medicinal purposes. Due to this situation, there are many retailers across Canada who are struggling very much because of the shortage of Cannabis in their retail shops.

One of the best products that is made from the Cannabis extract which retailers are willing to keep in their store is CBD. This is because in a study it has been noted that CBD is used for many medicinal purposes. It can also cure some types of diseases that are really dangerous. Such diseases include HIV and anxiety. And anxiety is the famous condition that is mainly caused due to the increase of depression.

Uses of CBD

CBD mainly occurs in solid form or in the oil form. The following are some of the best uses of the CBD isolate or CBD oil and they include:
Helps to cure all the pain.

Used for curing anxiety and insomnia.
Used to cure all of the symptoms that occur after the chemotherapy treatment.

The demand for CBD products

There are lots of companies who have started planting the Hemp plant just for the extraction of Cannabis and the making of CBD isolate and CBD oil. When the distribution of the psychoactive chemicals was announced, it was noted that businesses were mainly demanding for the Cannabis only. Simply because it has lots of health benefits compared to the drugs that are being used in the market today.

The food, beverages, creams and pain-relieving products consisting of CBD are expected to grow in the market as their demand is increasing. This is because of the approval by the government regarding the legalization of extracts and various edibles. A psychiatrist, Dr. Gabriella Gobbi, at McGill University said that even though the demand is increasing, the study and research of this area are limited, and something should be done for this.